Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 36

1.

Delineating the Tes Interaction Site in Zyxin and Studying Cellular Effects of Its Disruption.

Hadzic E, Catillon M, Halavatyi A, Medves S, Van Troys M, Moes M, Baird MA, Davidson MW, Schaffner-Reckinger E, Ampe C, Friederich E.

PLoS One. 2015 Oct 28;10(10):e0140511. doi: 10.1371/journal.pone.0140511. eCollection 2015.

2.

Human muscle LIM protein dimerizes along the actin cytoskeleton and cross-links actin filaments.

Hoffmann C, Moreau F, Moes M, Luthold C, Dieterle M, Goretti E, Neumann K, Steinmetz A, Thomas C.

Mol Cell Biol. 2014 Aug;34(16):3053-65. doi: 10.1128/MCB.00651-14. Epub 2014 Jun 16.

3.

Comparison of terazosin and prazosin for treatment of vesico-urethral reflex dyssynergia in dogs.

Haagsman AN, Kummeling A, Moes ME, Mesu SJ, Kirpensteijn J.

Vet Rec. 2013 Jul 13;173(2):41. doi: 10.1136/vr.101326. Epub 2013 Jun 19.

PMID:
23784060
4.

Routine versus aggressive upstream rhythm control for prevention of early atrial fibrillation in heart failure: background, aims and design of the RACE 3 study.

Alings M, Smit MD, Moes ML, Crijns HJ, Tijssen JG, Brügemann J, Hillege HL, Lane DA, Lip GY, Smeets JR, Tieleman RG, Tukkie R, Willems FF, Vermond RA, Van Veldhuisen DJ, Van Gelder IC.

Neth Heart J. 2013 Jul;21(7-8):354-63. doi: 10.1007/s12471-013-0428-5.

5.

Antiarrhythmic drug treatment after cardioversion of atrial fibrillation.

Smit MD, Moes ML, Van Gelder IC.

Lancet. 2012 Oct 27;380(9852):1467; author reply 1468. doi: 10.1016/S0140-6736(12)61831-5. No abstract available.

PMID:
23101705
6.

The importance of whether atrial fibrillation or heart failure develops first.

Smit MD, Moes ML, Maass AH, Achekar ID, Van Geel PP, Hillege HL, van Veldhuisen DJ, Van Gelder IC.

Eur J Heart Fail. 2012 Sep;14(9):1030-40. doi: 10.1093/eurjhf/hfs097. Epub 2012 Jun 25.

7.

A novel network integrating a miRNA-203/SNAI1 feedback loop which regulates epithelial to mesenchymal transition.

Moes M, Le Béchec A, Crespo I, Laurini C, Halavatyi A, Vetter G, Del Sol A, Friederich E.

PLoS One. 2012;7(4):e35440. doi: 10.1371/journal.pone.0035440. Epub 2012 Apr 13.

8.

Attachment of HeLa cells during early G1 phase.

Moes MJ, Bijvelt JJ, Boonstra J.

Histochem Cell Biol. 2011 Oct;136(4):399-411. doi: 10.1007/s00418-011-0852-9. Epub 2011 Aug 11.

9.

MIR@NT@N: a framework integrating transcription factors, microRNAs and their targets to identify sub-network motifs in a meta-regulation network model.

Le Béchec A, Portales-Casamar E, Vetter G, Moes M, Zindy PJ, Saumet A, Arenillas D, Theillet C, Wasserman WW, Lecellier CH, Friederich E.

BMC Bioinformatics. 2011 Mar 4;12:67. doi: 10.1186/1471-2105-12-67.

10.

Health at the center of health systems reform: how philosophy can inform policy.

Sturmberg JP, Martin CM, Moes MM.

Perspect Biol Med. 2010 Summer;53(3):341-56. doi: 10.1353/pbm.0.0169.

PMID:
20639604
11.

miR-661 expression in SNAI1-induced epithelial to mesenchymal transition contributes to breast cancer cell invasion by targeting Nectin-1 and StarD10 messengers.

Vetter G, Saumet A, Moes M, Vallar L, Le Béchec A, Laurini C, Sabbah M, Arar K, Theillet C, Lecellier CH, Friederich E.

Oncogene. 2010 Aug 5;29(31):4436-48. doi: 10.1038/onc.2010.181. Epub 2010 Jun 14.

12.

Quantitative kinetic study of the actin-bundling protein L-plastin and of its impact on actin turn-over.

Al Tanoury Z, Schaffner-Reckinger E, Halavatyi A, Hoffmann C, Moes M, Hadzic E, Catillon M, Yatskou M, Friederich E.

PLoS One. 2010 Feb 15;5(2):e9210. doi: 10.1371/journal.pone.0009210.

13.

Novel role of cPLA(2)alpha in membrane and actin dynamics.

Moes M, Boonstra J, Regan-Klapisz E.

Cell Mol Life Sci. 2010 May;67(9):1547-57. doi: 10.1007/s00018-010-0267-0. Epub 2010 Jan 29.

14.

Financial barriers and pricing strategies related to participation in sports activities: the perceptions of people of low income.

Steenhuis IH, Nooy SB, Moes MJ, Schuit AJ.

J Phys Act Health. 2009 Nov;6(6):716-21.

PMID:
20101914
15.

Time-resolved analysis of transcriptional events during SNAI1-triggered epithelial to mesenchymal transition.

Vetter G, Le Béchec A, Muller J, Muller A, Moes M, Yatskou M, Al Tanoury Z, Poch O, Vallar L, Friederich E.

Biochem Biophys Res Commun. 2009 Aug 7;385(4):485-91. doi: 10.1016/j.bbrc.2009.05.025. Epub 2009 May 12.

PMID:
19442650
16.

The talin rod IBS2 alpha-helix interacts with the beta3 integrin cytoplasmic tail membrane-proximal helix by establishing charge complementary salt bridges.

Rodius S, Chaloin O, Moes M, Schaffner-Reckinger E, Landrieu I, Lippens G, Lin M, Zhang J, Kieffer N.

J Biol Chem. 2008 Aug 29;283(35):24212-23. doi: 10.1074/jbc.M709704200. Epub 2008 Jun 23.

17.

The integrin binding site 2 (IBS2) in the talin rod domain is essential for linking integrin beta subunits to the cytoskeleton.

Moes M, Rodius S, Coleman SJ, Monkley SJ, Goormaghtigh E, Tremuth L, Kox C, van der Holst PP, Critchley DR, Kieffer N.

J Biol Chem. 2007 Jun 8;282(23):17280-8. Epub 2007 Apr 11.

18.

Signal transduction and actin in the regulation of G1-phase progression.

Boonstra J, Moes MJ.

Crit Rev Eukaryot Gene Expr. 2005;15(3):255-76. Review.

PMID:
16390321
19.
20.

Plato's conception of the relations between moral philosophy and medicine.

Moes M.

Perspect Biol Med. 2001 Summer;44(3):353-67.

PMID:
11482005
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk